Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for <i>HER2</i> -altered NSCLC: a retrospective real-world POLISH study

PaperCitations, authors & open-access status

First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for <i>HER2</i> -altered NSCLC: a retrospective real-world POLISH study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 40 citations, 2022 year and gold oa status.

40
Citations
2022
Year
gold
OA Status

Related on ScholarIQ

Xuezhi Hao
Author
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
Cancer Immunotherapy and Biomarkers
Topic
Lung Cancer Research Studies
Topic
470M+ articles · free account